Moderate-to-severe tricuspid regurgitation (TR) has a high prevalence in the general population, 1 and it progressively increases in older individuals, in whom it is close to 4%.
The global heart valve frame market is poised for significant growth over the coming years, driven by factors such as increasing prevalence of cardiovascular ...
Two patients at MedStar Union Memorial Hospital receive recently FDA-approved Evoque Tricuspid Valve Replacements for severe tricuspid regurgitation. "These groundbreaking procedures represent a ...
In medical devices, fourth-quarter sales were up 14%, to $5.05 billion—driven in part by the launch of TriClip, following its approval by the FDA for tricuspid valve repair in April 2024.
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
The Right Heart Pump The right heart pump consists of the right atrium, tricuspid valve, right ventricle, pulmonic valve, and pulmonary artery. Its job is to make sure “used” blood gets reloaded with ...
Significant tricuspid regurgitation (TR) is associated with increased morbidity and mortality. The development of transcatheter valve repair therapies has opened a wide range of opportunities for ...